Effects of ketamine on brain function during response inhibition.
Psychopharmacology December 2018 M Steffens, Claudia Neumann, A-M Kasparbauer et al.
The uncompetitive N-methyl-D-aspartate (NMDA) receptor (NMDAR) antagonist ketamine has been proposed to model symptoms of psychosis. Inhibitory deficits in the schizophrenia spectrum have been reliably reported using the antisaccade task. Interestingly, although similar antisaccade deficits have been reported following ketamine in non-human primates, ketamine-induced deficits have not been...
DOI: 10.1007/s00213-018-5081-7 (opens in new tab)
Full text (opens in new tab)
Ketamine
Antisaccades
Experimental model system
Eye movements
+3